A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry

Small molecule inhibitors of hepatitis C virus (HCV) are being developed to complement or replace treatments with pegylated interferons and ribavirin, which have poor response rates and significant side effects. Resistance to these inhibitors emerges rapidly in the clinic, suggesting that successful...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Baldick, Carl J., Wichroski, Michael J., Pendri, Annapurna, Walsh, Ann W., Fang, Jie, Mazzucco, Charles E., Pokornowski, Kevin A., Rose, Ronald E., Eggers, Betsy J., Hsu, Mayla, Zhai, Weixu, Zhai, Guangzhi, Gerritz, Samuel W., Poss, Michael A., Meanwell, Nicholas A., Cockett, Mark I., Tenney, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado: Public Library of Science 2010
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2936744/
https://ncbi.nlm.nih.gov/pubmed/20838466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.ppat.1001086
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares